The Claim
Serum interleukin-6 (IL-6) levels above 45.17 pg/mL are associated with a 69.6% sensitivity and 73.1% specificity for diagnosing coronary artery disease, with an area under the ROC curve of 0.770, indicating stronger diagnostic accuracy than TMAO.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A blood marker called interleukin-6 above 45.17 pg/mL correctly identifies 69.6% of people with coronary artery disease and correctly rules out 73.1% of people without it, performing better than another marker called TMAO.
See the scientific wording
Serum interleukin-6 (IL-6) levels above 45.17 pg/mL are associated with a 69.6% sensitivity and 73.1% specificity for diagnosing coronary artery disease, with an area under the ROC curve of 0.770, indicating stronger diagnostic accuracy than TMAO.
An imbalance in gut bacteria damages the intestinal barrier, allowing bacterial toxins to enter the blood. These toxins activate immune cells, which release large amounts of IL-6. High IL-6 triggers liver inflammation and causes blood vessel cells to multiply and form plaques that narrow the heart arteries. This process makes IL-6 a reliable indicator of heart disease severity.
What the research says
1 studyThis study found that when IL-6 levels in the blood are above 45.17 pg/mL, it correctly identifies about 70% of people with heart disease and 73% of those without it—better than TMAO, another blood marker. So yes, IL-6 is a more reliable sign for detecting heart disease in this group.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.